A formidable name among the COVID-19 vaccine developers, Moderna MRNA, impressed investors with a rally of 7.8% on Sep 9. The shares of the biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines soared as it informed about developing…
